Article
Upfront fecal microbiota transplantation for the management of immune checkpoint inhibitor mediated diarrhea and colitis
2025-01-13
Abstract excerpt
<title>Abstract</title> <p><bold>Introduction</bold>: Immune checkpoint inhibitors have revolutionized cancer therapy; however, adverse events from an unchecked immune system such as immune checkpoint inhibitor mediated diarrhea and colitis (IMDC) can develop. Fecal microbiota transplantation (FMT) remains an option for patients with refractory colitis, but has not been tested in an upfront setting. <bold>Methods...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 7d73910b-aadb-51c6-9b94-940361d87770
- DOI
- 10.21203/rs.3.rs-5455153/v1
